Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Qingdao University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Peng Chen's journey in medical research began with a strong foundation in clinical medicine and biomedical sciences. She earned her Bachelor of Medicine degree from Taishan Medical College (1999-2004), where she gained essential medical knowledge and clinical training. Her pursuit of advanced expertise led her to Capital University of Medical Sciences (2004-2007), where she obtained a Master of Science degree, focusing on medical research methodologies and specialized clinical studies. To further deepen her understanding and expertise, she pursued a Doctor of Medicine (2009-2012) at Qingdao University, refining her specialization in ophthalmology and regenerative medicine.

Professional Endeavors 🔬

After completing her master's degree, Prof. Chen embarked on her professional career at the Shandong Eye Institute (2007-2016), a renowned institution dedicated to ophthalmology research. During her tenure, she made significant contributions to vision sciences and ocular disease research, strengthening her expertise in eye-related disorders. In 2016, she transitioned to Qingdao University, where she currently serves as a leading researcher and faculty member. Her role at the university allows her to conduct cutting-edge research on ophthalmology and liver regeneration, mentor young medical scientists, and contribute to the advancement of medical science.

Contributions and Research Focus 🔍

Prof. Chen's research has significantly impacted liver regeneration, macrophage efferocytosis, and ophthalmology, particularly in understanding cellular mechanisms and disease pathophysiology. Some of her key contributions include:

  • Liver Regeneration and Macrophage Efferocytosis: Her recent studies have explored the NLRP3 inflammasome's role in constraining liver regeneration by impairing macrophage efferocytosis (Sci Adv., 2025). Additionally, she has investigated the role of Aquaporin-5 in facilitating liver regeneration via the ROS/GSDMD pathway (Cell Signal., 2025) and how extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury (Cell Death Discov., 2024).
  • Ophthalmology and Ocular Disease Research: She has studied the retinoic acid synthesis pathway in AQP5-deficient mice and its implications for dry eye disease (Invest Ophthalmol Vis Sci., 2024). Her research has also examined the regulation of axon guidance by Slit2 and Netrin-1 signaling in lacrimal gland development (Invest Ophthalmol Vis Sci., 2023).

Prof. Chen’s research not only deepens scientific knowledge in these areas but also paves the way for novel therapeutic strategies for liver and eye diseases.

Accolades and Recognition 🏆

Prof. Chen’s contributions to medical science have been widely recognized through prestigious research grants and peer-reviewed publications. She has received:

  • National Natural Science Foundation of China (2020-2023): RMB 550,000 for research on AQP5’s protective role in lens transparency through miRNA-mediated autophagy.
  • Shandong Provincial Natural Science Foundation (2018-2021): RMB 150,000 for the identification and functional study of Fuchs corneal endothelial dystrophy gene.

Her research has been featured in top-tier scientific journals, including Science Advances, Cell Signal, Cell Death Discovery, and Investigative Ophthalmology & Visual Science, reinforcing her status as a leading expert in regenerative medicine and ophthalmology.

Impact and Influence 🌍

Prof. Chen’s work bridges fundamental research and clinical applications, making a profound impact in both ophthalmology and liver disease treatment. Her findings on macrophage efferocytosis and aquaporins have opened new avenues for therapeutic interventions in liver regeneration, while her contributions to ocular disease mechanisms have enhanced the understanding of corneal and lacrimal gland pathophysiology.

Through her mentorship, collaborations, and academic contributions, she continues to shape the next generation of medical researchers and clinicians, strengthening Qingdao University’s reputation as a hub for medical research excellence.

Legacy and Future Contributions 🚀

With an established track record in liver regeneration and ophthalmic research, Prof. Peng Chen’s future contributions are expected to drive medical innovations in regenerative medicine and precision healthcare. Her work on cellular signaling pathways, extracellular vesicles, and aquaporins will likely inspire new therapeutic breakthroughs in both systemic and ocular diseases. As she continues to lead cutting-edge research, mentor young scientists, and contribute to transformative discoveries, Prof. Chen’s legacy will be one of scientific excellence, innovation, and meaningful impact on global healthcare.

Publications


  • 📄NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis

    • Journal: Science Advances
    • Year: 2025
    • Authors: Wei S, Guan G, Luan X, Yu C, Miao L, Yuan X, Chen P*, Di G*

  • 📄Aquaporin-5 facilitates liver regeneration following hepatectomy via ROS/GSDMD pathway

    • Journal: Cell Signaling
    • Year: 2025
    • Authors: Li B, Di G, Ge H, Song P, Han W, Sun H, Wang D, Chen P*, Wang Y*

  • 📄Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling

    • Journal: Cell Death Discovery
    • Year: 2024
    • Authors: Miao L, Yu C, Guan G, Luan X, Jin X, Pan M, Yang Y, Yan J, Chen P*, Di G*

  • 📄Reticulated Retinoic Acid Synthesis is Implicated in the Pathogenesis of Dry Eye in Aqp5 Deficiency Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2024
    • Authors: Ge H, Di G, Li B, Han W, Song P, Han S, Wang D*, Chen P*

  • 📄Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2023
    • Authors: Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D, Wang D*, Chen P*

 

Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Mr. Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

University of Ibadan | Nigeria

Author Profile

Orcid

Google Scholar

🌟 Early Academic Pursuits

Ridwan Salaam’s academic journey reflects a deep commitment to scientific excellence. His Bachelor’s degree from Obafemi Awolowo University (OAU) laid the foundation for his expertise in molecular genetics, with a thesis focused on the chromosomal studies of Arvicanthis niloticus. He graduated with a Second Class Upper degree, achieving a remarkable GPA of 4.19/5.0. Building on this, he pursued a Master’s degree at the University of Ibadan, earning a distinction (GPA: 6.2/7.0). His thesis investigated the antiplasmodial activity of phytocompounds using in silico pharmacology, supervised by esteemed scholars like Dr. Afolayan Funmilayo I.D.

🚀 Professional Endeavors

With hands-on research experience spanning academia and industry, Ridwan has excelled in roles such as Research Intern at Hackbio, Graduate Research Assistant at the University of Ibadan, and Research Assistant at OAU. He has mastered advanced bioinformatics tools, molecular docking, and statistical analysis, actively contributing to cancer and infectious disease studies. His contributions extend to mentoring students, conducting DNA extractions, and organizing independent research groups like the Computer-Aided Biological Research Group (COMBReG).

🧬 Contributions and Research Focus

Ridwan’s research spans Cell Biology, Molecular Genetics, Drug Discovery, and Immunotherapy, with an emphasis on cancer and infectious diseases. He has published extensively on computational drug discovery, molecular docking, and network pharmacology. Notable works include elucidating antiplasmodial mechanisms and exploring phytocompounds for cancer treatments. He has participated in groundbreaking projects, such as developing multipotent antivenom under the 2023 TETFUND National Research Fund.

🏆 Accolades and Recognition

Ridwan’s achievements have garnered national and international recognition. His certificate of commendation from Government Secondary School, Maina, acknowledges his teaching contributions, while multiple workshop certifications highlight his expertise in computer-aided drug design and vaccine development. His collaborative research efforts have been showcased at prestigious conferences like the Zoological Society of Nigeria Annual Conference and the International Conference on Scientific Research in Nigeria.

🌍 Impact and Influence

As a convener of COMBReG and a research team coordinator, Ridwan has demonstrated exceptional leadership by fostering collaborative environments and driving innovation. He has trained over 40 participants in bioinformatics and spearheaded projects addressing global health challenges like malaria and cancer. His ability to work across diverse cultural and professional backgrounds has solidified his reputation as a team player and mentor.

📜 Legacy and Future Contributions

Ridwan Salaam’s robust academic background and research endeavors position him as a trailblazer in molecular genetics and bioinformatics. His work not only addresses pressing global health issues but also inspires future generations of scientists. With ongoing research in computational drug discovery and molecular pathways, Ridwan’s contributions are poised to leave a lasting impact on the fields of cancer therapy and infectious disease treatment. His journey exemplifies the spirit of innovation and dedication, promising a legacy of transformative research.

 

Publications


📄 A Review of Selected Parasitic Plants in Nigeria: Converting Harms to Benefits

Authors: Funmilayo I. D. Afolayan, Ridwan A. Salaam, Ebenezer S. Oladokun, Samson D. Adesoye
Journal: Natural Therapy Advances
Year: 2024


📄 Antiplasmodial Mechanism of Lawsonia inermis: An In Silico-Based Investigation

Authors: Ridwan Abiodun Salaam, Funmilayo I. D. Afolayan
Journal: Infectious Diseases Research
Year: 2024


📄 In Silico Discovery of Potential Androgen Receptor and Cytochrome P450 17A1 Inhibitors from Camellia sinensis for Prostate Cancer Treatment

Authors: Ridwan Abiodun Salaam, Christopher Terseer Tarkaa, Rachael Pius Ebuh, Damilare Adebayo Olaniyi, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi, Olusola Abayomi Akangbe
Journal: Next Research
Year: 2024


📄 In Silico and In Vivo Evaluations of Multistage Antiplasmodial Potency and Toxicity Profiling of n-Hexadecanoic Acid Derived from Vernonia amygdalina

Authors: Funmilayo I. D. Afolayan, R. A. Odeyemi, Ridwan A. Salaam
Journal: Frontiers in Pharmacology
Year: 2024


📄 Elucidating the Molecular Targets of Curcuma longa for Breast Cancer Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

Authors: Christopher Terseer Tarkaa, Damilare Adebayo Oyaniyi, Ridwan Abiodun Salaam, Rachael Pius Ebuh, Olusola Abayomi Akangbe, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi
Journal: Precision Medicine Research
Year: 2023


 

Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Dr. Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Saveetha Medical College and Hospital | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Sakthivel Muthu’s academic journey began with a Bachelor's degree in Botany from Madurai Kamaraj University in 2005. He continued his education with an M.Sc. in Botany in 2007 and an M.Phil. in Botany from the University of Madras in 2008. His deep interest in plant sciences culminated in a Ph.D. in Botany from the University of Madras in 2016, where his thesis was highly commended.

👨‍🏫 Professional Endeavors

Dr. Muthu's professional career took off as a Post-Doctoral Fellow in Biotechnology at the University of Madras, supported by the prestigious UGC fellowship (2017–2022). He later transitioned into academia as a Guest Faculty member in Biotechnology at the same institution in 2023, bringing his expertise in bioactive compounds and protein biochemistry to students and peers alike.

🔬 Contributions and Research Focus

With a strong passion for interdisciplinary collaboration, Dr. Muthu has delved into various research fields, including protein biochemistry, enzymology, and bioactive compounds from plants and marine algae. His work extends to microbiology and cancer biology, aiming to unlock new therapeutic approaches through natural compounds. His notable contributions include research on phloroglucinol encapsulation for lung cancer and the antibacterial properties of lysozymes.

🏆 Accolades and Recognition

Dr. Muthu's contributions to science have been recognized with multiple awards and fellowships, such as:

  • UGC Post-Doctoral Fellowship (2017–2022)
  • Project Fellowship under the UGC’s BSR Fellowships (2010–2015)

He has also published several high-impact research papers in internationally renowned journals, contributing to fields like nanotechnology, enzymology, and phytochemistry.

🌍 Impact and Influence

Dr. Muthu's research has had a broad influence, particularly in understanding the bioactive properties of natural compounds and their potential in areas like cancer therapy and antibacterial applications. His work with nanoparticles and natural enzyme extraction has provided significant insights into sustainable biotechnological solutions.

🏅 Legacy and Future Contributions

Looking ahead, Dr. Muthu’s dedication to innovative biotechnological research and his willingness to collaborate across disciplines ensure that his contributions to science will continue to inspire future researchers. His ongoing projects, publications, and involvement in patent applications reflect his unwavering commitment to advancing our understanding of biochemistry and biotechnology.

 

Publications


  • 📄 Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Journal: Pharmaceutics
    • Date: 2024-10-05
    • Authors: Sakthivel Muthu, Mythileeswari Lakshmikanthan, Edwin Edward-Sam, Mutheeswaran Subramanian, Lakshmanan Govindan, Afrina Begum Mithen Patcha, Kathiravan Krishnan, Nallusamy Duraisamy, Selvakumari Jeyaperumal, Al Thabiani Aziz

  • 📄 A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Journal: Journal of Agriculture and Food Research
    • Date: 2024-06
    • Authors: Mythileeswari Lakshmikanthan, Sakthivel Muthu, Kathiravan Krishnan, Ammar B. Altemimi, Noor N. Haider, Lakshmanan Govindan, Jeyaperumal Selvakumari, Zina T. Alkanan, Francesco Cacciola, Yuvaraj Maria Francis

  • 📄 A Bioflocculant Made from Chitosan and Modified Shrimp Waste Might Collect Fresh and Saltwater Microalgae
    • Journal: Biosciences Biotechnology Research Asia
    • Date: 2024-03-30
    • Authors: Nallusamy Duraisamy, Sakthivel Muthu, Kumaran Thangavel, Kathiravan Krishnan, Sivamalar Sathasivam

  • 📄 Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis procera
    • Journal: European Food Research and Technology
    • Date: 2024-02-21
    • Authors: Sakthivel Muthu, Venkateshbabu Gopal, Zena Kadhim AL-Younis, Ammar B. Altemimi, Palani Perumal, Mythileeswari Lakshmikanthan, Kathiravan Krishnan, Mazin A. A. Najm, Angelo Maria Giuffrè, Lakshmanan Govindan

  • 📄 Viral Diseases of Ornamental Plants-III
    • Journal: Viral Diseases of Field and Horticultural Crops (Book Chapter)
    • Date: 2023
    • Authors: D. Sundararaj, S. Pushpanathan, S. Muthu, K. Krishnan

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa's academic journey commenced with a Bachelor's in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He pursued his passion further with a Master's in Biosciences from COMSATS University Islamabad, Pakistan, where he delved into cancer genetics. Currently, he is pursuing a Ph.D. in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDs, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

Jairus has garnered diverse professional experiences, from his tenure as a Laboratory Analyst at the Regional Veterinary Investigation Laboratory, Kenya, to his role as the Head of Public Needs Research at the Integrated Cancer Research Foundation of Kenya. He has contributed significantly to cancer education and research, both as a volunteer and in leadership positions, demonstrating his commitment to advancing cancer management in Kenya.

Contributions and Research Focus

With a strong background in biochemistry, genetics, and molecular biology, Jairus has dedicated his research efforts to elucidating the roles of non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker discovery, and DNA repair mechanisms. His research spans both experimental and computational domains, aiming to unravel the complexities of cancer genetics and improve therapeutic strategies.

Accolades and Recognition

Jairus's contributions to the field of cancer genetics have been recognized internationally. He has been awarded prestigious scholarships, including the Queen Elizabeth Commonwealth Scholarship, and has received honors for his academic achievements. Additionally, his research publications in reputable journals underscore his growing influence in the scientific community.

Impact and Influence

Through his research, leadership roles, and volunteer activities, Jairus has made a significant impact on cancer education, awareness, and research in Kenya. His work has contributed to the understanding of cancer pathogenesis and has paved the way for innovative approaches to cancer management and treatment.

Legacy and Future Contributions

As Jairus continues his doctoral studies and pursues his research interests in cancer genetics, he aims to leave a lasting legacy in the field through groundbreaking discoveries and transformative contributions. His multidisciplinary approach, coupled with his passion for scientific inquiry, positions him as a promising leader in cancer research with the potential to drive positive change in the global fight against cancer.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

 

 

 

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023